Telomir Pharmaceuticals (TELO) Earnings Date & Reports

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TELO is expected to report earnings to fall 92.41% to -5 cents per share on December 02

Telomir Pharmaceuticals TELO Stock Earnings Reports

Q3'26

Est.

$-0.06

Q2'26

Missed

by $0.75

Q1'26

Est.

$-0.03

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.01

The last earnings report on September 02 showed earnings per share of -79 cents, missing the estimate of -3 cents. With 19.27K shares outstanding, the current market capitalization sits at 79.09M.

View a ticker or compare two or three

TELO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for TELO